Clinical Trials Directory

Trials / Completed

CompletedNCT04583891

Mobile Apps to Reduce Distress in Breast Cancer Survivors Using an Adaptive Design

Evaluating a Mobile Application to Reduce Distress in Breast Cancer Survivors Using an Adaptive Design

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
313 (actual)
Sponsor
University of Virginia · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

The overarching goals of this project are to provide the first rigorous test of a scalable and publicly accessible mobile health intervention (IntelliCare) to address emotional distress in women with breast cancer, and to test the impact of human coaching as a way to increase engagement with digital health interventions to improve outcomes. To achieve these goals, an innovative experimental study design, known as a Sequential, Multiple Assignment, Randomized Trial (SMART), will be used to test the effects of the IntelliCare apps on symptoms of depression and anxiety, as well as the added value of human support to improve participant engagement. 313 breast cancer survivors diagnosed within the past 5 years and who screen positive for elevated symptoms of depression and/or anxiety will be recruited. Participants will initially be randomized to receive the IntelliCare apps or app-delivered patient education (control) for 8 weeks, and the impact of the IntelliCare apps on reducing symptoms of depression and anxiety in breast cancer survivors relative to control will be tested (Aim 1). We will monitor the app usage data of participants who receive the IntelliCare apps. Those who are high-engagers will continue to use the apps with no change. Those who are low-to-moderate engagers will be rerandomized after 1 week to either receive added coaching vs. not (i.e., no change) in addition to the apps. The hypothesis is that added coaching to address barriers to app usage will lead to greater engagement with the apps (Aim 2), for low-to-moderate engagers. Finally, semi-structured exit interviews will be conducted with participants that receive the IntelliCare apps and coaching. Interviews will capture survivors' perceptions about the extent to which, and how, tailoring the apps and coaching specifically for breast cancer survivors may improve intervention outcomes and engagement (Aim 3).

Conditions

Interventions

TypeNameDescription
BEHAVIORALIntelliCareIntelliCare is a self-guided, fully automated suite of 6 apps designed for brief, frequent check-ins to promote skill acquisition. IntelliCare has been shown in both general deployment and human-supported trials to be efficacious in reducing symptoms of depression and anxiety.
BEHAVIORALPsychoeducationThe Patient Education app will contain content relevant for general distress management. This includes information about thoughts/worries, prevalence of mood symptoms, CBT strategies for coping with negative affect, and other information typical of education-based mental health apps. The structure of this app will closely mirror patient education websites and apps which mimic the form and structure of apps that target cancer survivors and that primarily provide educational information about cancer and related symptoms.
BEHAVIORALCoachingThe randomization of added coaching vs. no added coaching after 1 week will only be carried out in the IntelliCare group. Coaching is a human supported approach to optimizing the use and benefit of the IntelliCare apps.

Timeline

Start date
2021-09-27
Primary completion
2024-01-16
Completion
2024-01-16
First posted
2020-10-12
Last updated
2025-11-10
Results posted
2025-03-18

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04583891. Inclusion in this directory is not an endorsement.